Clolar Related Clinical Trials
Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML [Completed]
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL [Active, not recruiting]
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome [Recruiting]
Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas [Recruiting]
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. [Completed]
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction [Completed]
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia [Completed]
Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia [Recruiting]
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias [Completed]
A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL) [Recruiting]
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) [Completed]
2 Arm Study of Clofarabine IV in MDS Patients [Completed]
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias [Active, not recruiting]
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) [Recruiting]
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS [Completed]
Allogeneic Stem Cell Transplant for Chronic Lymphocytic Leukemia (CLL) [Recruiting]
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). [Completed]
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) [Completed]
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) [Completed]
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Active, not recruiting]
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) [Active, not recruiting]
Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia [Not yet recruiting]
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Completed]
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation [Active, not recruiting]
Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Completed]
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen [Completed]
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable [Completed]
Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia [Recruiting]
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Recruiting]
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia [Terminated]
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant [Active, not recruiting]
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia [Completed]
Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx) [Terminated]
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Completed]
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Terminated]
Oral Clofarabine Study in Patients With Myelodysplastic Syndrome [Completed]
Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia [Completed]
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia [Recruiting]
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies [Active, not recruiting]
Oral Clofarabine for Acute Myeloid Leukemia [Completed]
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant [Recruiting]
A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma [Completed]
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL [Recruiting]
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) [Withdrawn]
Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis [Not yet recruiting]
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia [Completed]
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Completed]
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies [Completed]
Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) [Recruiting]
Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Responded to Treatment [Completed]
The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia [Withdrawn]
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia [Active, not recruiting]
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia. [Completed]
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia or Acute Leukemia in Remission [Recruiting]
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Terminated]
A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Completed]
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation [Terminated]
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia [Recruiting]
A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS) [Completed]
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia [Terminated]
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma [Completed]
Clofarabine Bone Marrow Cytoreduction [Completed]
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Completed]
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia [Completed]
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors [Completed]
Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients [Completed]
Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease [Terminated]
Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia [Completed]
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) [Not yet recruiting]
Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm [Active, not recruiting]
A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS) [Terminated]
Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Active, not recruiting]
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT [Completed]
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL [Completed]
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Recruiting]
Clofarabine in High Risk Myelodysplastic Syndrome (MDS) [Completed]
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia [Completed]
Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Recruiting]
Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) [Completed]
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) [Completed]
A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) [Completed]
Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years [Terminated]
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation [Suspended]
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias [Active, not recruiting]
Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes [Withdrawn]
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies [Active, not recruiting]
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia [Active, not recruiting]
Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults [Recruiting]
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) [Terminated]
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Terminated]
Bridging Study to Eliminate Presence of MRD for ALL Before HCT [Recruiting]
Clofarabine in Adult Patients With Advanced Solid Tumors [Completed]
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors [Recruiting]
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment [Active, not recruiting]
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes [Terminated]
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies [Completed]
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Completed]
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients [Completed]
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [Completed]
|
